Herbal medicines in the treatment of psychiatric disorders: A systematic review

被引:105
作者
Sarris, Jerome [1 ]
机构
[1] Univ Queensland, Dept Psychiat, Sch Med, Brisbane, Qld, Australia
关键词
herbal medicine; psychiatry; complementary medicine; medicinal plants; mood disorders; psychiatric disorders;
D O I
10.1002/ptr.2187
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This paper reports a critical review of 27 herbal medicines and formulas in treating a broad range of psychiatric disorders (in addition to anxiety and depression), including obsessive-compulsive, seasonal affective, bipolar depressive, psychotic, phobic and somatoform disorders. Ovid Medline, Pubmed and the Cochrane Library were searched for pharmacological and clinical evidence of herbal medicines with psychotropic activity. A forward search of later citations was also conducted. Whilst substantial high-quality evidence exists for the use of kava and St John's wort in the treatment of anxiety and depression respectively, currently there is insufficient. robust clinical evidence for the use of many other herbal medicines in psychiatric disorders. Phytotherapies which potentially have significant use in psychiatry, and urgently require more research are Rhodiola rosea (roseroot) and Crocus sativus (saffron) for depression; Passiflora incarnata (passionflower), Scutellaria lateriflora (scullcap) and Zizyphus jujuba (sour date) for anxiety disorders; and Piper methysticum (kava) for phobic, panic and obsessive-compulsive disorders. While depression and anxiety are commonly researched, the efficacy of herbal medicines in other mental disorders requires attention. The review addresses current issues in herbal psychotherapy: herbal safety, future areas of application, the relationship of herbal medicine with pharmaceuticals and the potential prescriptive integration of phytomedicines with synthetic psychotropic medicines. Particular attention is given to clinical and safety issues with St John's wort and kava. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:703 / 716
页数:14
相关论文
共 168 条
  • [41] KAVA PYRONES AND RESIN - STUDIES ON GABA-A, GABA-B AND BENZODIAZEPINE BINDING-SITES IN RODENT BRAIN
    DAVIES, LP
    DREW, CA
    DUFFIELD, P
    JOHNSTON, GAR
    JAMIESON, DD
    [J]. PHARMACOLOGY & TOXICOLOGY, 1992, 71 (02): : 120 - 126
  • [42] Severe adverse drug reactions of antidepressants:: Results of the German multicenter drug surveillance program AMSP
    Degner, D
    Grohmann, R
    Kropp, S
    Rüther, E
    Bender, S
    Engel, RR
    Schmidt, LG
    [J]. PHARMACOPSYCHIATRY, 2004, 37 : S39 - S45
  • [43] Comparative anxiolytic activity profile of various preparations of Passiflora incarnata Linneaus:: A comment on medicinal plants' standardization
    Dhawan, K
    Kumar, S
    Sharma, A
    [J]. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2002, 8 (03) : 283 - 291
  • [44] Coordinate induction of both cytochrome P4503A and MDRI by St John's wort in healthy subjects
    Dresser, GK
    Schwarz, UI
    Wilkinson, GR
    Kim, RB
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (01) : 41 - 50
  • [45] Herbal remedies for anxiety - a systematic review of controlled clinical trials
    Ernst, E
    [J]. PHYTOMEDICINE, 2006, 13 (03) : 205 - 208
  • [46] Fahmi Magdi, 2002, World J Biol Psychiatry, V3, P58, DOI 10.3109/15622970209150602
  • [47] A double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder
    Fava, M
    Alpert, J
    Nierenberg, AA
    Mischoulon, D
    Otto, MW
    Zajecka, J
    Murck, H
    Rosenbaum, JF
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (05) : 441 - 447
  • [48] Felter H. W., 2006, KINGS AM DISPENSATOR
  • [49] An open-label pilot study of St. John's wort in juvenile depression
    Findling, RL
    McNamara, NK
    O'Riordan, MA
    Reed, MD
    Demeter, CA
    Branicky, LA
    Blumer, JL
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2003, 42 (08) : 908 - 914
  • [50] Effect of sub-chronic treatment with Jarsin® (Extract of st John's wort, Hypericum perforatum) at two dose levels on evening salivary melatonin and cortisol concentrations in healthy male volunteers
    Franklin, M
    Hafizi, S
    Reed, A
    Hockney, R
    Murck, H
    [J]. PHARMACOPSYCHIATRY, 2006, 39 (01) : 13 - 15